During the past decade, Alabama Oncology, LLC conducted 19 clinical trials. In the 10-year time frame, 19 clinical trials started and 14 clinical trials were completed, i.e. on average, 73.7% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 11 clinical trials were completed. i.e. 137.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Alabama Oncology, LLC" #1 sponsor was "Radiation Therapy Oncology Group" with 34 trials, followed by "Bristol-Myers Squibb" with 5 trials sponsored, "Pfizer" with 3 trials sponsored, "Genentech, Inc." with 2 trials sponsored and "Hoffmann-La Roche" with 2 trials sponsored. Other sponsors include 12 different institutions and companies that sponsored additional 22 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Alabama Oncology, LLC" #1 collaborator was "National Cancer Institute (NCI)" with 35 trials as a collaborator, "NRG Oncology" with 3 trials as a collaborator, "Eastern Cooperative Oncology Group" with 2 trials as a collaborator, "North Central Cancer Treatment Group" with 2 trials as a collaborator and "Flatiron Health, Inc.; Foundation Medicine, Inc." with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "Alabama Oncology, LLC" are "Head and Neck Cancer" (8 trials), "Prostate Cancer" (6 trials), "Colorectal Cancer" (5 trials), "Lung Cancer" (5 trials) and "Metastatic Cancer" (5 trials). Many other conditions were trialed in "Alabama Oncology, LLC" in a lesser frequency.

Most popular intervention types in "Alabama Oncology, LLC" are "Drug" (46 trials), "Radiation" (30 trials), "Procedure" (14 trials), "Biological" (10 trials) and "Other" (5 trials). Other intervention types were less common.

The name of intervention was led by "radiation therapy" (26 trials), "conventional surgery" (8 trials), "paclitaxel" (7 trials), "cisplatin" (6 trials) and "filgrastim" (5 trials). Other intervention names were less common.

The vast majority of trials in "Alabama Oncology, LLC" are 56 trials for "All" genders, 5 trials for "Male" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Alabama Oncology, LLC". undefined are not yet recruiting, 4 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 48 completed trials in Alabama Oncology, LLC, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Alabama Oncology, LLC, 11 "Phase 1" clinical trials were conducted, 31 "Phase 2" clinical trials and 22 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".

Alabama Oncology, LLC has several departments that took part in Clinical trials: "Alabama Oncology St. Vincent's Birmingham" - 6 trials, "Alabama Oncology" - 3 trials